Close
Nordic 9Nordic 9

Mattias Ankerberg (investor - Angel Investor)

Sweden
See something wrong or missing? Let us know
Offices:Stockholm

Mattias Ankerberg works as CEO for Byggmax Group in Sweden

Average round investment:1.02M USD
Average number per year:1.0
Distribution: 2022 (1)
Portfolio companies: Sweden Sigrid Therapeutics
Mostly invests in: Sweden Sweden (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Mattias Ankerberg

Name Criteria
Sweden Gavia Food Holding
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Thomas Feldthus
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Hong Kong MCG Technology Group
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Andreas Ehn
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Sweden Axilium Capital
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
Sweden Fredrik Wester
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Sweden Gobia Enterprises
73%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Sweden Västkusten Affärsänglar
73%
  • Range for average deal size: 0.5M - 1M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United Kingdom Ben Holmes
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.6
  • Active last 12 months: Yes
Sweden CBC Investment Group
73%
  • Range for average deal size: 1M - 5M USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Top